Details
September 14, 2020
12:00PM - 1:00PM
MSHO Corporate Sponsor Zoom Meetings
Amgen, BeiGene, Coherus, Dova, EMD Serono, Jazz
Zoom Meeting
Do you miss having your favorite pharma reps visit your office? MSHO will be hosting a series of Zoom lunch meetings with some of our corporate sponsors. Join your colleagues and pharma friends for 25 minutes of education and seeing each others' smiling faces!
Registration has now closed.
12:00 pm - 12:25 pm Meetings:
- BeiGene
- Dova
- Overview: Clinical application of DOPTELET (Avatrombopag) for Adult Patients with Chronic Immune Thrombocytopenia (ITP) Who have had an Insufficient Response to a Previous Treatment.
- EMD Serono
- Overview: New indication for Bavencio (avelumab)
12:35 pm - 1:00 pm Meetings:
- Amgen
- Coherus
- Jazz
- Overview: Learn more about a new SCLC treatment option
For questions regarding this event, please contact MSHO at 248-385-5464 or email kblazevski@msho.org.
Printer-Friendly Version
Add to Calendar
aCLuDhaqizCaPxAftmqF167204
09/14/2020 12:00 PM
09/14/2020 01:00 PM
false
MSHO Corporate Sponsor Zoom Meetings
Do you miss having your favorite pharma reps visit your office? MSHO will be hosting a series of Zoom lunch meetings with some of our corporate sponsors. Join your colleagues and pharma friends for 25 minutes of education and seeing each others' smiling faces!
Registration has now closed.
12:00 pm - 12:25 pm Meetings:
BeiGene
Overview: BeiGene Update
Dova
Overview: Clinical application of DOPTELET (Avatrombopag) for Adult Patients with Chronic Immune Thrombocytopenia (ITP) Who have had an Insufficient Response to a Previous Treatment.
EMD Serono
Overview: New indication for Bavencio (avelumab)
12:35 pm - 1:00 pm Meetings:
Amgen
Overview: Amgen Update
Coherus
Overview: Coherus Update
Jazz
Overview: Learn more about a new SCLC treatment option
For questions regarding this event, please contact MSHO at 248-385-5464 or email kblazevski@msho.org.
Zoom Meeting